Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.270
-0.205 (-8.28%)
At close: Oct 16, 2026, 4:00 PM EDT
2.289
+0.019 (0.85%)
After-hours: Oct 16, 2026, 4:59 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $679.55 million as of October 16, 2026. It is the 12,011th most valuable company in the world and the 2,458th biggest in the United States. Its market cap has decreased by 56.20% in one year.
Market Cap
679.55M
Enterprise Value
600.00M
1-Year Change
-56.20%
Global Rank
Country Rank
#2,458 United States
Category
ChartMarket Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $679.55M, a decrease of -48.71%. That is a compound annual growth rate of -11.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 679.55M | -37.32% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 722.38M |
| Lexicon Pharmaceuticals | 716.38M |
| Apnimed | 714.80M |
| Annexon | 711.87M |
| Gyre Therapeutics | 711.49M |
| Inventiva | 708.14M |
| Immix Biopharma | 707.99M |
| Candel Therapeutics | 703.21M |